FMP
QuantRx Biomedical Corporation
QTXB
PNK
Inactive Equity
QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.
0.004 USD
-0.0009 (-22.5%)
About
ceo
Dr. Shalom Z. Hirschman M.D.
sector
Healthcare
industry
Medical - Instruments & Supplies
website
N/A
exchange
PNK
Description
QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vagin...
CIK
0000820608
ISIN
US74765N1090
CUSIP
74765N109
Address
10190 SW 90th Avenue
Phone
212 980 2235
Country
US
Employee
N/A
IPO Date
Jul 2, 2004
Summary
CIK
0000820608
Exchange
PNK
Industry
Medical - Instrument...
Sector
Healthcare
CUSIP
74765N109
ISIN
US74765N1090
Country
US
Price
0
Beta
-2.07
Volume Avg.
531
Market Cap
314.79k
Shares
-
52-Week
2.0E-4-0.01
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.4
P/B
-
Website
-
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest QTXB News
It looks like there's no news available.
